What causes alopecia areata?

Citations Over TimeTop 1% of 2013 papers

Abstract

The pathobiology of alopecia areata (AA), one of the most frequent autoimmune diseases and a major unsolved clinical problem, has intrigued dermatologists, hair biologists and immunologists for decades. Simultaneously, both affected patients and the physicians who take care of them are increasingly frustrated that there is still no fully satisfactory treatment. Much of this frustration results from the fact that the pathobiology of AA remains unclear, and no single AA pathogenesis concept can claim to be universally accepted. In fact, some investigators still harbour doubts whether this even is an autoimmune disease, and the relative importance of CD8(+) T cells, CD4(+) T cells and NKGD2(+) NK or NKT cells and the exact role of genetic factors in AA pathogenesis remain bones of contention. Also, is AA one disease, a spectrum of distinct disease entities or only a response pattern of normal hair follicles to immunologically mediated damage? During the past decade, substantial progress has been made in basic AA-related research, in the development of new models for translationally relevant AA research and in the identification of new therapeutic agents and targets for future AA management. This calls for a re-evaluation and public debate of currently prevalent AA pathobiology concepts. The present Controversies feature takes on this challenge, hoping to attract more skin biologists, immunologists and professional autoimmunity experts to this biologically fascinating and clinically important model disease.

Related Papers

• → Serum Zinc Concentration in Patients with Alopecia Areata(2023)13 cited
• → Prevalence of Comorbid Conditions and Sun-Induced Skin Cancers in Patients with Alopecia Areata(2015)27 cited
• → Congenital Alopecia areata(1997)27 cited
• Study of IFN-γ and IL-10 Levels in Serum of Patients with Alopecia Areata(2004)
• → Evidence Based Treatment of Alopecia Areata(2017)